Gelatin methacryloyl and Laponite bioink for 3D bioprinted organotypic tumor modeling.
3D bioprinting
gelatin methacryloyl
nanoengineered composite hydrogel
organotypic
pancreatic cancer
silicate nanoplatelet
Journal
Biofabrication
ISSN: 1758-5090
Titre abrégé: Biofabrication
Pays: England
ID NLM: 101521964
Informations de publication
Date de publication:
20 07 2023
20 07 2023
Historique:
received:
01
03
2023
accepted:
22
06
2023
pmc-release:
20
07
2024
medline:
21
7
2023
pubmed:
23
6
2023
entrez:
22
6
2023
Statut:
epublish
Résumé
Three-dimensional (3D)
Identifiants
pubmed: 37348491
doi: 10.1088/1758-5090/ace0db
pmc: PMC10683563
mid: NIHMS1944580
doi:
Substances chimiques
laponite
D703131383
gelatin methacryloyl
0
Gelatin
9000-70-8
Hydrogels
0
Biological Factors
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : R01 CA257558
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL140951
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK130566
Pays : United States
Organisme : NIGMS NIH HHS
ID : SC1 GM121182
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL137193
Pays : United States
Informations de copyright
© 2023 IOP Publishing Ltd.
Références
J Proteome Res. 2022 Sep 2;21(9):2197-2210
pubmed: 35972904
J Cell Biol. 2017 Nov 6;216(11):3799-3816
pubmed: 29021221
PLoS One. 2017 Jul 27;12(7):e0182039
pubmed: 28750018
Environ Res. 2015 Apr;138:233-54
pubmed: 25732897
Cancers (Basel). 2019 Mar 07;11(3):
pubmed: 30866547
RSC Adv. 2020 Jul 7;10(43):25652-25661
pubmed: 35518607
Biomater Sci. 2018 Jul 24;6(8):2073-2083
pubmed: 29944151
Pathol Res Pract. 1993 Jun;189(5):527-9
pubmed: 8104328
Korean J Intern Med. 2004 Mar;19(1):10-4
pubmed: 15053037
Acta Biomater. 2018 Apr 1;70:35-47
pubmed: 29425720
ACS Appl Mater Interfaces. 2018 Mar 28;10(12):9957-9968
pubmed: 29461795
Signal Transduct Target Ther. 2020 Aug 25;5(1):166
pubmed: 32843638
PLoS One. 2014 Mar 07;9(3):e89899
pubmed: 24608521
Front Oncol. 2021 Jun 14;11:683788
pubmed: 34195085
Langmuir. 2018 Jan 23;34(3):917-925
pubmed: 28981287
Biomed Mater. 2020 Dec 16;16(1):015021
pubmed: 33325382
Front Mol Biosci. 2020 Mar 06;7:33
pubmed: 32211418
Nat Rev Mater. 2021;6(5):372-373
pubmed: 33936776
Biomaterials. 2015 Dec;73:254-71
pubmed: 26414409
ACS Appl Mater Interfaces. 2018 Jul 5;10(26):21891-21900
pubmed: 29889487
Differentiation. 2010 Jan;79(1):21-30
pubmed: 19726123
Adv Mater. 2019 Jun;31(23):e1900332
pubmed: 30941811
Nat Med. 2013 Nov;19(11):1423-37
pubmed: 24202395
J Exp Med. 2017 Mar 6;214(3):579-596
pubmed: 28232471
Biochim Biophys Acta Mol Basis Dis. 2018 Mar;1864(3):793-803
pubmed: 29253515
Front Oncol. 2022 Nov 18;12:1052132
pubmed: 36465388
Biotechnol J. 2020 Aug;15(8):e1900456
pubmed: 32107862
Chem Rev. 2020 Oct 14;120(19):11028-11055
pubmed: 32856892
Nat Biotechnol. 2014 Aug;32(8):773-85
pubmed: 25093879
Oncogene. 2015 Jan 8;34(2):263-8
pubmed: 24469057
Acta Biomater. 2020 Sep 1;113:1-22
pubmed: 32622053
Adv Sci (Weinh). 2017 Nov 24;5(3):1700550
pubmed: 29593958
Tissue Eng Part A. 2021 Jun;27(11-12):679-702
pubmed: 33499750
Mol Cancer. 2003 Jan 07;2:5
pubmed: 12537586
Biomaterials. 2015 Sep;63:24-34
pubmed: 26072995
Trends Cancer. 2021 Mar;7(3):249-264
pubmed: 33218948
Nanoscale. 2022 Jan 20;14(3):797-814
pubmed: 34951427
Biomolecules. 2020 Dec 12;10(12):
pubmed: 33322749
Mol Oncol. 2013 Dec;7(6):1031-42
pubmed: 23998958
Biofabrication. 2017 Jul 25;9(3):034103
pubmed: 28691691
Biofabrication. 2021 Apr 09;13(3):
pubmed: 32650324
Bioengineering (Basel). 2019 Aug 28;6(3):
pubmed: 31466260
Cell Death Dis. 2019 May 10;10(5):375
pubmed: 31076571
Nat Med. 2018 May;24(5):541-550
pubmed: 29686425
Mater Sci Eng C Mater Biol Appl. 2021 Jan;118:111519
pubmed: 33255074
Sci Rep. 2018 Feb 12;8(1):2802
pubmed: 29434327
Sci Rep. 2017 Jul 17;7(1):5586
pubmed: 28717157
PLoS One. 2016 Aug 03;11(8):e0159912
pubmed: 27487118
Bioeng Transl Med. 2023 Apr 05;8(3):e10518
pubmed: 37206224
Lab Invest. 2018 Jan;98(1):27-40
pubmed: 29155423
J Hematol Oncol. 2019 Aug 28;12(1):86
pubmed: 31462327
ACS Appl Mater Interfaces. 2020 Oct 7;12(40):44563-44577
pubmed: 32966746
Trends Cancer. 2019 Feb;5(2):128-142
pubmed: 30755305
ACS Nano. 2014 Oct 28;8(10):9833-42
pubmed: 25221894
Sci Transl Med. 2016 Nov 16;8(365):365ra156
pubmed: 27856795
Cancers (Basel). 2022 Feb 27;14(5):
pubmed: 35267539
Nanoscale. 2016 Jun 16;8(24):12362-72
pubmed: 27270567
Cell Commun Signal. 2023 May 4;21(1):96
pubmed: 37143134
Theranostics. 2020 Apr 6;10(11):5074-5089
pubmed: 32308769
Appl Phys Rev. 2018 Dec;5(4):041106
pubmed: 32550960
Curr Pharm Biotechnol. 2011 Dec;12(12):2158-64
pubmed: 21619533
Nat Rev Clin Oncol. 2020 Sep;17(9):527-540
pubmed: 32398706
Cell Commun Signal. 2020 Apr 7;18(1):59
pubmed: 32264958
Acta Biomater. 2018 Jul 15;75:11-34
pubmed: 29803007
Nanoscale. 2022 Jan 6;14(2):350-360
pubmed: 34908077
Acta Biomater. 2018 Jan;65:112-122
pubmed: 29128532
ACS Appl Mater Interfaces. 2017 Dec 20;9(50):43449-43458
pubmed: 29214803
Adv Mater. 2013 Jun 25;25(24):3329-36
pubmed: 23670944
Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):E3905-E3913
pubmed: 29643075
Cancer Lett. 2019 Jun 28;452:237-243
pubmed: 30905814
Oncol Rep. 2017 Apr;37(4):1971-1979
pubmed: 28260082
Adv Healthc Mater. 2022 Apr;11(7):e2102054
pubmed: 34990081
Artif Cells Nanomed Biotechnol. 2018 Dec;46(8):1799-1808
pubmed: 29065727
Biomaterials. 2014 Nov;35(33):9087-99
pubmed: 25123923
Bioact Mater. 2023 Feb 15;25:360-373
pubmed: 36879666
Nat Mater. 2011 Jan;10(1):56-60
pubmed: 21151164
Adv Sci (Weinh). 2020 Nov 30;8(1):2003327
pubmed: 33437588
Nat Mater. 2009 Jul;8(7):543-57
pubmed: 19525947
J Colloid Interface Sci. 2005 Mar 15;283(2):397-405
pubmed: 15721911
Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2050-5
pubmed: 17267609
Sci Rep. 2023 Feb 21;13(1):3051
pubmed: 36810872
Ann Surg Oncol. 2019 Dec;26(13):4191-4192
pubmed: 31605319
Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9607-11
pubmed: 15210946